Pain relief and associated factors in patients undergoing vertebroplasty due to osteoporotic vertebral fracture

被引:9
|
作者
Etemadifar, Mohammad Reza [1 ]
Andalib, Ali [1 ]
Farzinnia, Saeed [1 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Orthoped Surg, Hezar Jarib Blvd, Esfahan, Iran
来源
INTERNATIONAL JOURNAL OF BURNS AND TRAUMA | 2020年 / 10卷 / 05期
关键词
Vertebroplasty; pain; osteoporosis; VAS; CERVICAL-SPINE FRACTURES; PERCUTANEOUS VERTEBROPLASTY; KYPHOPLASTY; AUGMENTATION; MANAGEMENT; EPIDEMIOLOGY;
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Osteoporotic vertebral fracture (OVF) is a common spinal fracture in the elderly population treated with conservative or surgical techniques. Patients with such fractures may experience chronic pain due to nonunion and instability, deformity with kyphosis and neurologic symptoms due to neural compression. Surgical interventions have definite roles in treatments especially when conservative therapy fails. Cement augmentation in forms of vertebroplasty and kyphoplasty or even surgical fixation with or without column reconstruction are among our armamentarium to deal with problems arising during the treatment of these patients. Methods: We entered patients with OVF who did not respond to conservative treatments for more than 4 weeks and were candidates for vertebroplasty. Pain Visual Analog Scale (PVAS) was assessed for patients before the procedure, in the first month and 6 months after surgeries. We also analyzed factors including time passed from fractures, amounts of injected cement, age, sex, types of fractures, segmental kyphosis and sites of fractures. Data were collected and analyzed using SPSS software version 24. Results: A total number of 140 patients entered. The mean age of the patients was 64.90 +/- 7.97 years. Mean preoperative pain level was 8.35 +/- 0.97 points on VAS (0-10) score. The mean Post-operative VAS score after one month and after six months were 4.65+0.66 and 5.28 +/- 0.75 respectively. The mean consumed cement volume was 5.77+1.40 ml. Cement volume of more than 5 ml was injected for 53.6% of patients. 78.7% of fractures were located in T10-L2 levels (thoracolumbar fractures). 14.2% of fractures in L3-L5 (lumbar fractures) and 7.1% in T4-T9 (thoracic fractures). 53.6% of the patients had kyphosis levels below 20 degrees. Reduction of pain in patients younger than 60 years was more than patients older than 60 years but both groups indicated pain reduction (P<0.001). The end-plate fracture had a higher likelihood of pain relief compared with burst or retropulsed fractures (OR=1.161). Patients with thoracolumbar fractures had higher chances of pain reduction compared with other locations (OR=1.870). Kyphosis less than 20 degrees and also cement volume more than 5 ml had also significant effects on reducing the pain after surgeries (OR=2.054 and OR=2.412 respectively (P<0.05)). Conclusion: Vertebroplasty is an effective option in treating patients with OVF who have not respond to conservative treatment. Factors such as younger age, OVFs involving either end-plates, more than 5 ml of cement injection, segmental kyphosis below 20 degrees and thoracolumbar fractures are associated with better results for pain amelioration.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 50 条
  • [31] Analysis of Pre- and Postoperative Pain Variation in Osteoporotic Vertebral Compression Fracture Patients Undergoing Kyphoplasty
    Mei, Xin
    Sun, Zhi-yong
    Zhou, Feng
    Luo, Zong-ping
    Yang, Hui-lin
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5994 - 6000
  • [32] Osteoporotic vertebral compression fracture - Treatment with kyphoplasty and vertebroplasty
    Bernardo, Wanderley Marques
    Anhesini, Mauricio
    Buzzini, Renata
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (03): : 204 - 207
  • [33] The Prognostic Factors Influencing on the Therapeutic Effect of Percutaneous Vertebroplasty in Treating Osteoporotic Vertebral Compression Fractures
    Ryu, Kyeong-Sik
    Park, Chun Kun
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2009, 45 (01) : 16 - 23
  • [34] Identification of the predictive factors of new vertebral fractures in a cohort of patients who underwent a vertebroplasty for osteoporotic fracture
    Penet, Clemence
    Grados, Franck
    Cottenet, Jonathan
    Michel, David
    Deramond, Herve
    Fardellone, Patrice
    PRESSE MEDICALE, 2019, 48 (10): : 1175 - 1177
  • [35] Percutaneous curved vertebroplasty for osteoporotic vertebral compression fracture
    Lu, Anqi
    Wang, Xiaoping
    Huang, Daoqiang
    Feng, Weili
    ASIAN JOURNAL OF SURGERY, 2022, 45 (10) : 2050 - 2051
  • [36] Percutaneous vertebroplasty: option of treatment for osteoporotic vertebral fracture
    Figueiredo, N
    Amaral, JC
    Serra, AD
    Nogueira, AM
    Garcia, VCS
    Weissheimer, FL
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 625 - 630
  • [37] Effects of teriparatide versus percutaneous vertebroplasty on pain relief, quality of life and cost-effectiveness in postmenopausal females with acute osteoporotic vertebral compression fracture: A prospective cohort study
    Ma, Yangyang
    Wu, Xiaoliang
    Xiao, Xiao
    Ma, Yao
    Feng, Lan
    Yan, Wenjuan
    Chen, Jianting
    Yang, Dehong
    BONE, 2020, 131
  • [38] Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures
    Farrokhi, Majid Reza
    Alibai, Ehsanali
    Maghami, Zohre
    JOURNAL OF NEUROSURGERY-SPINE, 2011, 14 (05) : 561 - 569
  • [39] Management of Vertebral Re-Fractures after Vertebroplasty in Osteoporotic Patients
    Guarnieri, G.
    Ambrosanio, G.
    Pezzullo, M. G.
    Zeccolini, E.
    Vassallo, P.
    Galasso, R.
    Lavanga, A.
    Muto, M.
    INTERVENTIONAL NEURORADIOLOGY, 2009, 15 (02): : 153 - 157
  • [40] Efficacy of pedicle screw fixation and vertebroplasty treatment of severe osteoporotic thoracolumbar vertebral compression fractures in senior patients
    Wei, Qingshen
    Zhang, Xiangwei
    Wu, Yadong
    Cui, Enlong
    Liu, Zhiliang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (12): : 9465 - 9472